VIDEO ACCESS:

RELEASE: October 5, 2016
EXPIRATION: December 31, 2017 (Credit is not available after this expiration date)

PRESENTER:  Charles Nemeroff, M.D., Ph.D.
TITLE:  Paradise Lost:  The Neurobiology of Child Abuse and Neglect

Learning Objectives

  • Summarize how gene effects are relevant to neurological mechanisms.
  • Explain how a gene variation effects brain development and function so that the risk of a depressive episode is increased.
  • Describe how early life experience alters response of adult neurogenesis and the treatment implications.

ACCREDITATION:

Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Mayo Clinic College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensuracte with the extent of their participation in the activity.

INSTRUCTIONS:

  • Select the Take Course button below.
  • Participate in the quiz.  Participants must pass by a minimum of 80%, 1 re-take is allowed.  Quizzes will have between 2-5 questions.
  • Complete the evaluation.

TRANSCRIPT:
This credit will appear on your Transcript for permanent record.  To access your transcript, visit My Account, My Activities, Transcript

DISCLOSURE SUMMARY:
As a provider accredited by ACCME, Mayo Clinic College of Medicine (Mayo School of Continuous Professional Development), must ensure balance, independence, objectivity and scientific rigor in its educational activities.   Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity.  Safeguards against commercial bias have been put in place.  Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.  Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed…

Relevant financial relationship(s) with industry: 

Charles Nemeroff, M.D., Ph.D. 

Research/Grants:

National Institutes of Health (NIH)

Consulting (last three years):

Xhale, Takeda, Mitsubishi Tanabe Pharma Development America, Taisho Pharmaceutical Inc., Lundbeck, Prismic Pharmaceuticals, Bracket (Clintara), Total Pain Solutions (TPS), Gerson Lehrman Group (GLG) Healthcare & Biomedical Council, Fortress Biotech, Sunovion Pharmaceuticals Inc., Sumitomo Dainippon Pharma.

Stockholder:

Xhale, Celgene, Seattle Genetics, Abbvie, OPKO Health, Inc., Bracket Intermediate Holding Corp., Network Life Sciences Inc.

Scientific Advisory Boards:

American Foundation for Suicide Prevention (AFSP), Brain and Behavior Research Foundation (BBRF) (formerly named National Alliance for Research on Schizophrenia and Depression [NARSAD]), Xhale, Anxiety Disorders Association of America (ADAA), Skyland Trail, Bracket (Clintara), RiverMend Health LLC, Laureate Institute for Brain Research, Inc.

Board of Directors:

AFSP, Gratitude America, ADAA

Income sources or equity of $10,000 or more:

American Psychiatric Publishing, Xhale, Bracket (Clintara), CME Outfitters, Takeda

Patents:

Method and devices for transdermal delivery of lithium (US 6,375,990B1)

Method of assessing antidepressant drug therapy via transport inhibition of monoamine neurotransmitters by ex vivo assay (US 7,148,027B2)

 
No relevant financial relationship(s) with industry:

Brian Palmer, M.D., Michael Bostwick, M.D., Karen Grothe, Ph.D., Lois Krahn, M.D., Jarrod Leffler, Ph.D., Larissa Loukianova, M.D., Mary Machulda, Ph.D., Patricia Maus, M.D., Amber Pearson, Jeffrey Staab, M.D., Cosima Swintak, M.D., Kristin Vickers Douglas, Ph.D., Cynthia Harbeck-Weber, Ph.D., Michael Zaccariello, Ph.D. 

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:

Charles Nemeroff, M.D., Ph.D. - None

QUESTIONS?
MAYO STAFF: Contact rstpsychgr@mayo.edu
MAYO CLINIC CARE NETWORK MEMBERS:  Contact cme@mayo.edu 

Presenter: 
Charles Nemeroff, M.D., Ph.D.
Where did the idea for the course originate?: 
Minnesota
Please login or register to take this course.
Where did the idea for the course originate?: 
Minnesota